COMPASS Pathways (CMPS) News Today → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free CMPS Stock Alerts $6.94 +0.03 (+0.43%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 2:10 AM | americanbankingnews.comCOMPASS Pathways (NASDAQ:CMPS) versus Applied Therapeutics (NASDAQ:APLT) Financial SurveyJune 5, 2024 | marketbeat.comAffinity Asset Advisors LLC Takes Position in COMPASS Pathways plc (NASDAQ:CMPS)Affinity Asset Advisors LLC bought a new stake in shares of COMPASS Pathways plc (NASDAQ:CMPS - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 550,000 shares of the company's stock, valuMay 21, 2024 | fool.comThese 2 Catalysts Could Soon Send Compass Pathways Stock SoaringMay 13, 2024 | finance.yahoo.comCOMPASS Pathways plc (NASDAQ:CMPS) Q1 2024 Earnings Call TranscriptMay 13, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $120.00 price objective on shares of COMPASS Pathways in a research report on Monday.May 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for COMPASS Pathways Amid Strong Financials and Promising Clinical TrialsMay 9, 2024 | fool.comCompass Pathways Plc (CMPS) Q1 2024 Earnings Call TranscriptMay 8, 2024 | msn.comCMPS Stock Earnings: Compass Pathways Misses EPS for Q1 2024May 8, 2024 | globenewswire.comCompass Pathways Announces First Quarter 2024 Financial Results and Business HighlightsMay 8, 2024 | globenewswire.comCompass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderMay 7, 2024 | insidertrades.comCOMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder George Jay Goldsmith Sells 9,621 SharesMay 6, 2024 | marketbeat.comInsider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells 9,621 Shares of StockCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder George Jay Goldsmith sold 9,621 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $8.29, for a total transaction of $79,758.09. Following the transaction, the insider now owns 3,966,052 shares in the company, valued at approximately $32,878,571.08. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.May 6, 2024 | marketbeat.comCOMPASS Pathways (CMPS) Set to Announce Quarterly Earnings on WednesdayCOMPASS Pathways (NASDAQ:CMPS) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.May 3, 2024 | globenewswire.comCompass Pathways to announce first quarter financial results on May 8, 2024May 2, 2024 | globenewswire.comCompass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatmentApril 30, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Trading 5.4% Higher COMPASS Pathways (NASDAQ:CMPS) Trading 5.4% HigherApril 30, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating on shares of COMPASS Pathways in a report on Tuesday.April 29, 2024 | globenewswire.comCompass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depressionApril 25, 2024 | seekingalpha.comCOMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?April 20, 2024 | benzinga.comCompass Pathways Stock (NASDAQ:CMPS), Analyst Ratings, Price Targets, PredictionsApril 19, 2024 | insidertrades.comCOMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder George Jay Goldsmith Sells 23,881 SharesApril 18, 2024 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $203,704.93 in StockCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder George Jay Goldsmith sold 23,881 shares of the firm's stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of $8.53, for a total value of $203,704.93. Following the completion of the transaction, the insider now owns 3,986,523 shares in the company, valued at $34,005,041.19. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.April 18, 2024 | marketbeat.comCOMPASS Pathways' (CMPS) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of COMPASS Pathways in a report on Thursday.April 16, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Trading 4.6% Higher COMPASS Pathways (NASDAQ:CMPS) Shares Up 4.6%April 9, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Shares Gap Down to $9.74COMPASS Pathways (NASDAQ:CMPS) Shares Gap Down to $9.74April 5, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Shares Down 3.6% COMPASS Pathways (NASDAQ:CMPS) Trading Down 3.6%April 4, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Trading 5.6% Higher COMPASS Pathways (NASDAQ:CMPS) Stock Price Up 5.6%April 4, 2024 | investing.comCompass Pathways insider sells over $460k in sharesApril 3, 2024 | insidertrades.comInsider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells 25,750 Shares of StockApril 1, 2024 | globenewswire.comCompass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare ConferenceApril 1, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $8.32COMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $8.32April 1, 2024 | markets.businessinsider.comBuy Rating on COMPASS Pathways: COMP360’s Market Potential and Promising TRD TherapyApril 1, 2024 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Ekaterina Malievskaia Sells 25,750 SharesCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder Ekaterina Malievskaia sold 25,750 shares of the company's stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $8.65, for a total value of $222,737.50. Following the completion of the transaction, the insider now directly owns 4,036,154 shares of the company's stock, valued at approximately $34,912,732.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.April 1, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Coverage Initiated at Morgan StanleyMorgan Stanley began coverage on shares of COMPASS Pathways in a research note on Monday. They set an "overweight" rating and a $30.00 price target on the stock.April 1, 2024 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Receives Consensus Rating of "Buy" from BrokeragesShares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have received a consensus rating of "Buy" from the five research firms that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month targMarch 31, 2024 | finance.yahoo.com20 Most Depressed Countries in AsiaMarch 30, 2024 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Sees Large Decrease in Short InterestCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 3,150,000 shares, a drop of 15.8% from the February 29th total of 3,740,000 shares. Based on an average trading volume of 680,400 shares, the short-interest ratio is currently 4.6 days.March 30, 2024 | uk.investing.comCompass Pathways co-founders step down from boardMarch 28, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseCOMPASS Pathways (NASDAQ:CMPS) Sees Unusually-High Trading VolumeMarch 28, 2024 | globenewswire.comCompass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of DirectorsMarch 28, 2024 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Shares Bought by ARK Investment Management LLCARK Investment Management LLC raised its holdings in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 7.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,618,871 shares of the company's stock after purchasing anMarch 19, 2024 | markets.businessinsider.comBuy Rating Affirmed for COMPASS Pathways Amid Promising Neuropsychiatric Treatment AdvancesMarch 16, 2024 | investing.comCompass Pathways director sells over $700k in company sharesMarch 15, 2024 | insidertrades.comCOMPASS Pathways plc (NASDAQ:CMPS) Director Sells $166,529.20 in StockMarch 14, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Stock Price Down 8.4%COMPASS Pathways (NASDAQ:CMPS) Shares Down 8.4%March 7, 2024 | marketbeat.comBrokers Set Expectations for COMPASS Pathways plc's FY2024 Earnings (NASDAQ:CMPS)COMPASS Pathways plc (NASDAQ:CMPS - Free Report) - Investment analysts at Cantor Fitzgerald lifted their FY2024 EPS estimates for shares of COMPASS Pathways in a report issued on Monday, March 4th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will post earnings of ($2.47)March 5, 2024 | fool.com3 Biopharma Stocks You Don't Want to Miss in the New Bull MarketMarch 3, 2024 | marketbeat.comArmistice Capital LLC Acquires New Stake in COMPASS Pathways plc (NASDAQ:CMPS)Armistice Capital LLC acquired a new stake in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 400,000 shares of the company's stock, valued at approximately $2,960,000. Armistice Capital LLC owned approMarch 1, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Stock Price Up 11.6%COMPASS Pathways (NASDAQ:CMPS) Stock Price Up 11.6%March 1, 2024 | marketbeat.comCOMPASS Pathways' (CMPS) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and set a $120.00 price objective on shares of COMPASS Pathways in a report on Friday. Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report CMPS Media Mentions By Week CMPS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPS News Sentiment▼0.920.76▲Average Medical News Sentiment CMPS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPS Articles This Week▼22▲CMPS Articles Average Week Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TVTX News Today SAGE News Today MGNX News Today PRAX News Today NRIX News Today RPTX News Today PMVP News Today ARVN News Today CPRX News Today GLPG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMPS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored